Jari Laurikka

Medicine & Life Sciences

1. Acute Coronary Syndrome 59%
2. Adenosine 33%
3. Air 20%
4. Aortic Valve 28%
5. Aquaporins 36%
6. Atrial Appendage 35%
7. Atrial Fibrillation 50%
8. Biomarkers 28%
9. Cadaver 27%
10. Clinical Trials 18%
11. Cohort Studies 25%
12. Confidence Intervals 36%
13. Coronary Artery Bypass 90%
14. Coronary Artery Disease 21%
15. Coronary Disease 25%
16. Diazoxide 38%
17. Disease Progression 24%
18. Electric Impedance 28%
19. Genome 19%
20. Heart 26%
21. Heart Ventricles 25%
22. Idiopathic Pulmonary Fibrosis 22%
23. Interstitial Lung Diseases 54%
24. Length of Stay 17%
25. Lung 54%
26. Meta-Analysis 23%
27. Mortality 65%
28. Muscles 28%
29. Myocardial Infarction 29%
30. Myocardial Ischemia 53%
31. Odds Ratio 24%
32. Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha 46%
33. Photoplethysmography 41%
34. Pneumothorax 30%
35. Postoperative Complications 27%
36. Pressure 18%
37. Prospective Studies 20%
38. Quality of Life 36%
39. Randomized Controlled Trials 21%
40. RNA 24%
41. Sternotomy 33%
42. Stroke 17%
43. Surgical Instruments 27%
44. Survival 18%
45. Thoracic Surgery 100%
46. Transcriptome 26%
47. Vacuum 32%
48. Vibration 31%
49. Wound Infection 58%
50. Wrist 27%